Merck & Company Inc (MRK)

Current ratio

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Total current assets US$ in thousands 32,168,000 31,954,000 29,977,000 33,402,000 35,722,000 33,561,000 32,116,000 31,184,000 30,266,000 31,058,000 28,665,000 26,909,000 27,764,000 26,577,000 29,343,000 26,174,000 27,483,000 26,142,000 24,298,000 25,351,000
Total current liabilities US$ in thousands 25,694,000 23,094,000 23,394,000 23,131,000 24,239,000 22,998,000 23,168,000 22,316,000 23,872,000 23,728,000 21,906,000 26,361,000 27,327,000 20,405,000 22,178,000 23,483,000 22,220,000 20,684,000 20,085,000 18,543,000
Current ratio 1.25 1.38 1.28 1.44 1.47 1.46 1.39 1.40 1.27 1.31 1.31 1.02 1.02 1.30 1.32 1.11 1.24 1.26 1.21 1.37

December 31, 2023 calculation

Current ratio = Total current assets ÷ Total current liabilities
= $32,168,000K ÷ $25,694,000K
= 1.25

The current ratio measures a company's ability to cover its short-term liabilities with its short-term assets. A higher current ratio indicates better liquidity and financial health.

Looking at Merck & Co Inc's current ratio over the past eight quarters, we can see some fluctuations. In Q4 2023, the current ratio was 1.25, which decreased from the previous quarter but was still above 1, indicating that the company had sufficient current assets to cover its current liabilities.

In the preceding quarters, the current ratio ranged between 1.28 to 1.47, showing relative stability and consistency in managing short-term obligations. The trend indicates that Merck & Co Inc has maintained a healthy liquidity position, with assets easily convertible into cash to meet its short-term obligations.

Overall, the company's current ratio has remained within a reasonable range, suggesting effective management of working capital and a strong financial position to meet its short-term obligations. It is essential to continue monitoring this ratio to ensure ongoing liquidity and financial stability.


Peer comparison

Dec 31, 2023


See also:

Merck & Company Inc Current Ratio (Quarterly Data)